Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Exagen Inc's Business Segments
Exagen Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 20
Regions Reported
-
Revenue Share by Reportable Segment - Q2 FY2026
- Reportable100%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 20 | 100% |
Description of Exagen Inc
Exagen Inc. is a leading diagnostic company that specializes in the development and delivery of advanced testing solutions for autoimmune diseases. The company was founded in 2002 and is headquartered in Albuquerque, New Mexico, with additional offices and laboratory facilities in California, Colorado, and Mexico.
Exagen Inc. focuses on providing comprehensive testing options to physicians and patients to accurately diagnose autoimmune diseases. Autoimmune diseases are conditions where the immune system mistakenly attacks and damages healthy tissues and organs in the body. These diseases can be difficult to diagnose due to their complex and varied symptoms, making accurate testing crucial for proper treatment.
The company's flagship product is called AVISE® testing, which stands for advanced diagnostic solutions for autoimmune and inflammatory diseases. AVISE® testing utilizes a proprietary technology called Cell-Bound Complement Activation Products (CB-CAPs) to identify and quantify autoimmune disease biomarkers in patient samples. By measuring these biomarkers, AVISE® testing can help differentiate between different autoimmune diseases and provide insights into disease activity and progression.
Exagen Inc. offers a wide range of AVISE® tests, including AVISE® Lupus, AVISE® Vasculitis, AVISE® Rheumatoid Arthritis, AVISE® SLE Prognostic, and AVISE® CTD. These tests are designed to assist physicians in diagnosing and monitoring patients with conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other connective tissue diseases (CTDs).
The company's laboratory facilities are certified under the Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) standards. This ensures the accuracy and reliability of their testing procedures, and they are committed to providing high-quality results to healthcare providers and patients.
In addition to their diagnostic testing services, Exagen Inc. also invests in research and development to continuously improve their testing methodologies and expand their test menu. They collaborate with leading academic institutions and healthcare professionals to stay at the forefront of autoimmune disease diagnostics. This commitment to innovation has allowed them to develop advanced testing solutions that are both sensitive and specific in detecting autoimmune diseases.
Exagen Inc. demonstrates a strong commitment to patient care and education. They offer various resources, including patient support programs, educational materials, and webinars, to help patients and their families better understand autoimmune diseases and navigate their healthcare journeys.
In summary, Exagen Inc. is a diagnostic company that specializes in providing advanced testing solutions for autoimmune diseases. With their proprietary AVISE® testing technology and dedication to research and development, they are making significant contributions to the field of autoimmune disease diagnostics.
Exagen Inc. focuses on providing comprehensive testing options to physicians and patients to accurately diagnose autoimmune diseases. Autoimmune diseases are conditions where the immune system mistakenly attacks and damages healthy tissues and organs in the body. These diseases can be difficult to diagnose due to their complex and varied symptoms, making accurate testing crucial for proper treatment.
The company's flagship product is called AVISE® testing, which stands for advanced diagnostic solutions for autoimmune and inflammatory diseases. AVISE® testing utilizes a proprietary technology called Cell-Bound Complement Activation Products (CB-CAPs) to identify and quantify autoimmune disease biomarkers in patient samples. By measuring these biomarkers, AVISE® testing can help differentiate between different autoimmune diseases and provide insights into disease activity and progression.
Exagen Inc. offers a wide range of AVISE® tests, including AVISE® Lupus, AVISE® Vasculitis, AVISE® Rheumatoid Arthritis, AVISE® SLE Prognostic, and AVISE® CTD. These tests are designed to assist physicians in diagnosing and monitoring patients with conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other connective tissue diseases (CTDs).
The company's laboratory facilities are certified under the Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) standards. This ensures the accuracy and reliability of their testing procedures, and they are committed to providing high-quality results to healthcare providers and patients.
In addition to their diagnostic testing services, Exagen Inc. also invests in research and development to continuously improve their testing methodologies and expand their test menu. They collaborate with leading academic institutions and healthcare professionals to stay at the forefront of autoimmune disease diagnostics. This commitment to innovation has allowed them to develop advanced testing solutions that are both sensitive and specific in detecting autoimmune diseases.
Exagen Inc. demonstrates a strong commitment to patient care and education. They offer various resources, including patient support programs, educational materials, and webinars, to help patients and their families better understand autoimmune diseases and navigate their healthcare journeys.
In summary, Exagen Inc. is a diagnostic company that specializes in providing advanced testing solutions for autoimmune diseases. With their proprietary AVISE® testing technology and dedication to research and development, they are making significant contributions to the field of autoimmune disease diagnostics.
Exagen Inc is a biotechnology company that specializes in developing and providing diagnostic solutions primarily focused on autoimmune diseases. Their primary offerings are directed towards aiding clinicians in diagnosing and managing these complex and often difficult-to-treat conditions. Below is an extensive overview of their segments, products, and services.
Segments
1. Diagnostic Testing: This segment focuses on developing and offering proprietary tests designed to help healthcare providers diagnose and manage autoimmune diseases. Exagen is particularly known for its focus on rheumatoid arthritis and other related conditions.
2. Therapeutic Monitoring: In addition to diagnosing diseases, Exagen provides services related to monitoring patient treatment responses. This plays a crucial role in treatment management, ensuring patients receive the most effective therapies based on their unique disease profiles.
3. Research and Development: Continuous innovation is essential in the biotech sector, and Exagen invests significantly in R&D to expand their test offerings and improve existing technologies. This segment also involves working towards the development of potential new therapeutics and diagnostics for other autoimmune conditions.
Products
1. Avise® Diagnostics: This is a suite of autoimmune diagnostic tests that Exagen has developed to help healthcare providers diagnose conditions like rheumatoid arthritis (RA), lupus, and other autoimmune diseases.
- Avise® RA: This specific test is aimed at aiding in the diagnosis of rheumatoid arthritis. It incorporates a multi-faceted approach, considering clinical symptoms, patient history, and various biomarkers.
- Avise® Lupus: Focused on patients with systemic lupus erythematosus (SLE), this test provides valuable data to assist clinicians in diagnosing lupus, understanding disease activity, and monitoring treatment responses.
2. Patient Services: Exagen offers services that ensure patients and healthcare providers get comprehensive support throughout the diagnostic journey.
- Patient Education: Providing comprehensive resources and information for patients to understand their conditions better and the role of testing in their management.
- Support Programs: These may include navigation through the testing process, insurance and coding assistance, and guidance on accessing results.
3. Compliance and Quality Testing: Exagen prides itself on maintaining high standards of quality in its tests. This includes rigorous compliance with regulatory standards and protocols related to laboratory testing, ensuring the reliability and accuracy of interpretations.
Services
1. Laboratory Services: Exagen operates its own clinical laboratory, where they conduct extensive testing on samples received from clinicians. Their lab is equipped with state-of-the-art technology and adheres to strict quality control guidelines.
2. Consultative Services: Exagen offers consultative support to healthcare providers, assisting them in interpreting the results of diagnostic tests and integrating these results into comprehensive care plans for patients.
3. Education and Training: They also provide educational resources and training for healthcare providers on autoimmune diseases, diagnostic testing, and the clinical implications of their findings. This is aimed at enhancing clinician knowledge and improving patient outcomes.
4. Health Economics and Outcomes Research: Understanding the economic implications of autoimmune diseases and their management is critical for health systems. Exagen engages in health economics research to highlight the value of their tests and services in real-world settings.
5. Custom Solutions: For selected partners and research institutions, Exagen may provide tailored diagnostic solutions or research collaborations aimed at exploring novel biomarkers and treatments in autoimmune conditions.
Overall, Exagen Inc is focused on improving the lives of patients with autoimmune diseases through its innovative testing and monitoring solutions. Their integrative approach not only facilitates diagnosis but also enhances ongoing management, ensuring that patients receive personalized and effective care.
Segments
1. Diagnostic Testing: This segment focuses on developing and offering proprietary tests designed to help healthcare providers diagnose and manage autoimmune diseases. Exagen is particularly known for its focus on rheumatoid arthritis and other related conditions.
2. Therapeutic Monitoring: In addition to diagnosing diseases, Exagen provides services related to monitoring patient treatment responses. This plays a crucial role in treatment management, ensuring patients receive the most effective therapies based on their unique disease profiles.
3. Research and Development: Continuous innovation is essential in the biotech sector, and Exagen invests significantly in R&D to expand their test offerings and improve existing technologies. This segment also involves working towards the development of potential new therapeutics and diagnostics for other autoimmune conditions.
Products
1. Avise® Diagnostics: This is a suite of autoimmune diagnostic tests that Exagen has developed to help healthcare providers diagnose conditions like rheumatoid arthritis (RA), lupus, and other autoimmune diseases.
- Avise® RA: This specific test is aimed at aiding in the diagnosis of rheumatoid arthritis. It incorporates a multi-faceted approach, considering clinical symptoms, patient history, and various biomarkers.
- Avise® Lupus: Focused on patients with systemic lupus erythematosus (SLE), this test provides valuable data to assist clinicians in diagnosing lupus, understanding disease activity, and monitoring treatment responses.
2. Patient Services: Exagen offers services that ensure patients and healthcare providers get comprehensive support throughout the diagnostic journey.
- Patient Education: Providing comprehensive resources and information for patients to understand their conditions better and the role of testing in their management.
- Support Programs: These may include navigation through the testing process, insurance and coding assistance, and guidance on accessing results.
3. Compliance and Quality Testing: Exagen prides itself on maintaining high standards of quality in its tests. This includes rigorous compliance with regulatory standards and protocols related to laboratory testing, ensuring the reliability and accuracy of interpretations.
Services
1. Laboratory Services: Exagen operates its own clinical laboratory, where they conduct extensive testing on samples received from clinicians. Their lab is equipped with state-of-the-art technology and adheres to strict quality control guidelines.
2. Consultative Services: Exagen offers consultative support to healthcare providers, assisting them in interpreting the results of diagnostic tests and integrating these results into comprehensive care plans for patients.
3. Education and Training: They also provide educational resources and training for healthcare providers on autoimmune diseases, diagnostic testing, and the clinical implications of their findings. This is aimed at enhancing clinician knowledge and improving patient outcomes.
4. Health Economics and Outcomes Research: Understanding the economic implications of autoimmune diseases and their management is critical for health systems. Exagen engages in health economics research to highlight the value of their tests and services in real-world settings.
5. Custom Solutions: For selected partners and research institutions, Exagen may provide tailored diagnostic solutions or research collaborations aimed at exploring novel biomarkers and treatments in autoimmune conditions.
Overall, Exagen Inc is focused on improving the lives of patients with autoimmune diseases through its innovative testing and monitoring solutions. Their integrative approach not only facilitates diagnosis but also enhances ongoing management, ensuring that patients receive personalized and effective care.